Is LENSAR, Inc. (LNSR) Halal?

NASDAQ Healthcare United States $73M
✗ NOT HALAL
Confidence: 90/100
LENSAR, Inc. (LNSR) is Not Halal under AAOIFI Standard 21. The company's impermissible income ratio of 45.74% exceeds the 5% threshold allowed under AAOIFI. LENSAR, Inc. operates in the Healthcare sector.

Shariah Screening — 5 Standards

Based on financial data from December 2024

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 1.9%
/ 30%
15.9%
/ 30%
4.6%
/ 30%
45.74%
/ 5%
✗ NOT HALAL
DJIM 1.9%
/ 33%
15.9%
/ 33%
4.6%
/ 33%
45.74%
/ 5%
✗ NOT HALAL
MSCI 3.9%
/ 33%
33.9%
/ 33%
9.8%
/ 33%
45.74%
/ 5%
✗ NOT HALAL
S&P 1.9%
/ 33%
15.9%
/ 33%
4.6%
/ 33%
45.74%
/ 5%
✗ NOT HALAL
FTSE 3.9%
/ 33%
33.9%
/ 33%
9.8%
/ 50%
45.74%
/ 5%
✗ NOT HALAL

Financial Highlights

EPS
$-4.37
P/B Ratio
-2.8
EV/EBITDA
-17.2
EV: $72M
Revenue
$53M
Growth: 5.7%
Beta
0.7
Low volatility
Current Ratio
1.2

Profitability

Gross Margin 46.1%
Operating Margin -16.1%
Net Margin -87.1%
Return on Equity (ROE) -422.3%
Return on Assets (ROA) -8.2%

Cash Flow & Balance Sheet

Operating Cash Flow-$2M
Free Cash Flow-$2M
Total Debt$3M
Current Ratio1.2
Total Assets$66M

Price & Trading

Last Close$5.52
50-Day MA$10.93
200-Day MA$11.78
Avg Volume85K
Beta0.7
52-Week Range
$5.35
$14.31

About LENSAR, Inc. (LNSR)

CEO
Mr. Nicholas T. Curtis
Employees
140
Sector
Healthcare
Industry
Medical Devices
Country
United States
Exchange
NASDAQ
Market Cap
$73M
Currency
USD

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System. The company offers LENSAR Laser System which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is LENSAR, Inc. (LNSR) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), LENSAR, Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is LENSAR, Inc.'s debt ratio?

LENSAR, Inc.'s debt ratio is 1.9% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 3.9%.

What are LENSAR, Inc.'s key financial metrics?

LENSAR, Inc. has a market capitalization of $73M, and revenue of $53M. The company maintains a gross margin of 46.1% and a net margin of -87.1%. Return on equity stands at -422.3%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.